AADACL4
gene geneOn this page
Also known as OTTHUMG00000001889
Summary
AADACL4 (arylacetamide deacetylase like 4, HGNC:32038) is a protein-coding gene on chromosome 1p36.21, encoding Arylacetamide deacetylase-like 4 (Q5VUY2).
Predicted to enable carboxylic ester hydrolase activity. Predicted to be located in membrane.
Source: NCBI Gene 343066 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 79 total — 1 pathogenic
- MANE Select transcript:
NM_001013630
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:32038 |
| Approved symbol | AADACL4 |
| Name | arylacetamide deacetylase like 4 |
| Location | 1p36.21 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | OTTHUMG00000001889 |
| Ensembl gene | ENSG00000204518 |
| Ensembl biotype | protein_coding |
| Entrez | 343066 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000376221
RefSeq mRNA: 1 — MANE Select: NM_001013630
NM_001013630
CCDS: CCDS30590
Canonical transcript exons
ENST00000376221 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001368020 | 12665961 | 12667076 |
| ENSE00001375909 | 12661791 | 12661854 |
| ENSE00001387205 | 12651123 | 12651339 |
| ENSE00001469777 | 12644085 | 12644714 |
Expression profiles
Bgee: expression breadth broad, 47 present calls, max score 54.32.
Top tissues by expression
108 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| omental fat pad | UBERON:0010414 | 54.32 | gold quality |
| metanephros cortex | UBERON:0010533 | 52.35 | gold quality |
| endometrium | UBERON:0001295 | 48.60 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 46.78 | gold quality |
| myometrium | UBERON:0001296 | 45.43 | gold quality |
| placenta | UBERON:0001987 | 45.03 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 44.99 | gold quality |
| endocervix | UBERON:0000458 | 44.68 | gold quality |
| kidney | UBERON:0002113 | 44.21 | gold quality |
| body of uterus | UBERON:0009853 | 43.64 | gold quality |
| lymph node | UBERON:0000029 | 43.54 | gold quality |
| stromal cell of endometrium | CL:0002255 | 43.34 | silver quality |
| left uterine tube | UBERON:0001303 | 43.33 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 43.23 | gold quality |
| vagina | UBERON:0000996 | 42.93 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 42.84 | silver quality |
| cortex of kidney | UBERON:0001225 | 42.28 | gold quality |
| uterine cervix | UBERON:0000002 | 41.59 | gold quality |
| colonic epithelium | UBERON:0000397 | 41.55 | gold quality |
| prostate gland | UBERON:0002367 | 40.96 | gold quality |
| ectocervix | UBERON:0012249 | 40.27 | gold quality |
| urinary bladder | UBERON:0001255 | 39.95 | gold quality |
| muscle tissue | UBERON:0002385 | 39.35 | gold quality |
| fallopian tube | UBERON:0003889 | 38.58 | gold quality |
| adipose tissue | UBERON:0001013 | 38.40 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 38.13 | gold quality |
| colon | UBERON:0001155 | 37.79 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 37.58 | silver quality |
| spleen | UBERON:0002106 | 37.43 | gold quality |
| fundus of stomach | UBERON:0001160 | 36.83 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 2.95 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
20 targeting AADACL4, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4533 | 100.00 | 69.48 | 2758 |
| HSA-MIR-4283 | 100.00 | 66.42 | 2097 |
| HSA-MIR-512-3P | 99.97 | 67.35 | 1049 |
| HSA-MIR-548AN | 99.97 | 70.91 | 2817 |
| HSA-MIR-3910 | 99.95 | 71.13 | 2227 |
| HSA-MIR-539-5P | 99.93 | 70.30 | 2855 |
| HSA-MIR-6835-3P | 99.93 | 70.49 | 2904 |
| HSA-MIR-205-3P | 99.92 | 69.92 | 3165 |
| HSA-MIR-95-5P | 99.89 | 72.17 | 3973 |
| HSA-MIR-629-3P | 99.85 | 67.99 | 1875 |
| HSA-MIR-1290 | 99.59 | 69.90 | 2079 |
| HSA-MIR-6716-5P | 99.56 | 68.62 | 1244 |
| HSA-MIR-5004-3P | 99.54 | 68.27 | 1371 |
| HSA-MIR-3123 | 99.47 | 67.15 | 2693 |
| HSA-MIR-522-3P | 98.91 | 68.56 | 1817 |
| HSA-MIR-3145-3P | 98.85 | 69.07 | 2031 |
| HSA-MIR-4260 | 98.78 | 65.37 | 848 |
| HSA-MIR-5699-5P | 97.36 | 67.03 | 1014 |
| HSA-MIR-7161-3P | 96.79 | 68.79 | 798 |
| HSA-MIR-5586-5P | 96.29 | 68.02 | 685 |
Cross-species orthologs
13 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | si:dkey-193c22.1 | ENSDARG00000093687 |
| mus_musculus | Aadacl4fm1 | ENSMUSG00000028593 |
| mus_musculus | AAdacl4fm3 | ENSMUSG00000041735 |
| mus_musculus | Aadacl4 | ENSMUSG00000070609 |
| mus_musculus | Aadacl4fm5 | ENSMUSG00000078504 |
| mus_musculus | Aadacl4fm4 | ENSMUSG00000078505 |
| rattus_norvegicus | Aadacl4fm1 | ENSRNOG00000026782 |
| rattus_norvegicus | AAdacl4fm3l1 | ENSRNOG00000037027 |
| rattus_norvegicus | Aadacl4 | ENSRNOG00000037030 |
| rattus_norvegicus | AAdacl4fm3 | ENSRNOG00000042808 |
| caenorhabditis_elegans | WBGENE00009186 | |
| caenorhabditis_elegans | WBGENE00011642 | |
| caenorhabditis_elegans | WBGENE00017515 |
Paralogs (5): AADAC (ENSG00000114771), NCEH1 (ENSG00000144959), AFMID (ENSG00000183077), AADACL3 (ENSG00000188984), AADACL2 (ENSG00000197953)
Protein
Protein identifiers
Arylacetamide deacetylase-like 4 — Q5VUY2 (reviewed: Q5VUY2)
All UniProt accessions (1): Q5VUY2
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Membrane.
Similarity. Belongs to the ‘GDXG’ lipolytic enzyme family.
RefSeq proteins (1): NP_001013652* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR013094 | AB_hydrolase_3 | Domain |
| IPR017157 | Arylacetamide_deacetylase | Family |
| IPR029058 | AB_hydrolase_fold | Homologous_superfamily |
| IPR050300 | GDXG_lipolytic_enzyme | Family |
Pfam: PF07859
UniProt features (10 total): active site 3, topological domain 2, glycosylation site 2, chain 1, transmembrane region 1, short sequence motif 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5VUY2-F1 | 96.05 | 0.94 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Catalytic / active sites (3): 193; 347; 377
Glycosylation sites (2): 168, 269
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 9 (showing top):
GOMF_HYDROLASE_ACTIVITY_ACTING_ON_ESTER_BONDS, GOMF_CARBOXYLIC_ESTER_HYDROLASE_ACTIVITY, chr1p36, PEDRIOLI_MIR31_TARGETS_UP, MIR95_5P, MIR539_5P, MIR1290, MIR6716_5P, DESCARTES_MAIN_FETAL_IGFBP1_DKK1_POSITIVE_CELLS
GO Biological Process (0):
GO Molecular Function (2): carboxylic ester hydrolase activity (GO:0052689), hydrolase activity (GO:0016787)
GO Cellular Component (1): membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| hydrolase activity, acting on ester bonds | 1 |
| catalytic activity | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
942 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| AADACL4 | RNF223 | E7ERA6 | 623 |
| AADACL4 | PRXL2C | Q7RTV5 | 488 |
| AADACL4 | RNF148 | Q8N7C7 | 422 |
| AADACL4 | C9J5N1 | C9J5N1 | 406 |
| AADACL4 | TIFAB | Q6ZNK6 | 400 |
| AADACL4 | ELOF1 | P60002 | 393 |
| AADACL4 | AAGAB | Q6PD74 | 388 |
| AADACL4 | AAR2 | Q9Y312 | 386 |
| AADACL4 | AAMDC | Q9H7C9 | 372 |
| AADACL4 | A4GNT | Q9UNA3 | 371 |
| AADACL4 | QTRT2 | Q9H974 | 370 |
| AADACL4 | AARSD1 | Q9BTE6 | 363 |
| AADACL4 | TLX2 | O43763 | 358 |
| AADACL4 | ALDH5A1 | P51649 | 348 |
| AADACL4 | ABAT | P80404 | 348 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| P | psi-mi:“MI:0914”(association) | 0.350 |
ESM2 similar proteins: A2A7Z8, A7LB60, P08910, P0DKC5, P0DKC6, P22760, P70683, P83006, Q05AK6, Q0P5B7, Q13093, Q14032, Q1LZ86, Q28017, Q32LS6, Q4R2Y9, Q4V8A1, Q502J0, Q5EA42, Q5PPS7, Q5VUY0, Q5VUY2, Q5XI64, Q5ZJL8, Q5ZKL5, Q60963, Q63276, Q6DHN0, Q6GLL2, Q6IE26, Q6P093, Q7L211, Q7M370, Q7SY73, Q7Z5M8, Q802V6, Q80UX8, Q8BM81, Q8IUS5, Q8R2Y0
Diamond homologs: A2A7Z8, B2GV54, O53424, P15304, P16386, P22760, P54310, P95125, P9WK86, P9WK87, Q0P5B7, Q1JQE6, Q5R8Y5, Q5VUY0, Q5VUY2, Q68J42, Q6L545, Q6P093, Q6PIU2, Q7M370, Q8BLF1, Q8BM81, Q8KQK1, Q940G6, Q99PG0, Q9QZH8, A0A0H5BMX5, A0A2P1GIY2, A1A8E2, A7ZIN6, A7ZXD4, B1IZB8, B1LJN4, B1XFR3, B2U4S9, B5Z3Y7, B6I0B9, B7L7A1, B7M3W8, B7MDZ8
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
79 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 64 |
| Likely benign | 12 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 144297 | GRCh38/hg38 1p36.23-36.21(chr1:9064492-12666744)x1 | Pathogenic |
SpliceAI
836 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:12644712:TTGG:T | donor_loss | 0.9900 |
| 1:12644714:GGT:G | donor_loss | 0.9900 |
| 1:12644715:G:GA | donor_loss | 0.9900 |
| 1:12644715:G:GG | donor_gain | 0.9900 |
| 1:12644716:TGAG:T | donor_loss | 0.9900 |
| 1:12644717:GAGT:G | donor_loss | 0.9900 |
| 1:12650376:ATT:A | acceptor_gain | 0.9900 |
| 1:12651337:TGGGT:T | donor_loss | 0.9900 |
| 1:12651338:GG:G | donor_gain | 0.9900 |
| 1:12651339:GG:G | donor_gain | 0.9900 |
| 1:12651340:G:GC | donor_loss | 0.9900 |
| 1:12651341:T:TT | donor_loss | 0.9900 |
| 1:12664998:GCT:G | donor_gain | 0.9900 |
| 1:12665956:TTTAG:T | acceptor_loss | 0.9900 |
| 1:12665957:TTA:T | acceptor_loss | 0.9900 |
| 1:12665960:G:GT | acceptor_loss | 0.9900 |
| 1:12644673:T:G | donor_gain | 0.9800 |
| 1:12644711:TTTG:T | donor_gain | 0.9800 |
| 1:12650376:A:AG | acceptor_gain | 0.9800 |
| 1:12650377:T:G | acceptor_gain | 0.9800 |
| 1:12651117:CAACA:C | acceptor_loss | 0.9800 |
| 1:12651120:CA:C | acceptor_loss | 0.9800 |
| 1:12651121:A:T | acceptor_loss | 0.9800 |
| 1:12651122:GGGGA:G | acceptor_gain | 0.9800 |
| 1:12651313:G:GT | donor_gain | 0.9800 |
| 1:12651331:G:GT | donor_gain | 0.9800 |
| 1:12651332:GAGCC:G | donor_gain | 0.9800 |
| 1:12651340:G:GG | donor_gain | 0.9800 |
| 1:12665959:A:AG | acceptor_gain | 0.9800 |
| 1:12665960:G:GG | acceptor_gain | 0.9800 |
AlphaMissense
2666 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:12666538:A:C | S343R | 0.987 |
| 1:12666540:C:A | S343R | 0.987 |
| 1:12666540:C:G | S343R | 0.987 |
| 1:12666088:A:C | S193R | 0.938 |
| 1:12666090:C:A | S193R | 0.938 |
| 1:12666090:C:G | S193R | 0.938 |
| 1:12666590:T:C | L360S | 0.930 |
| 1:12666679:T:C | F390L | 0.928 |
| 1:12666681:C:A | F390L | 0.928 |
| 1:12666681:C:G | F390L | 0.928 |
| 1:12666587:G:C | R359P | 0.922 |
| 1:12666560:G:C | R350P | 0.921 |
| 1:12666637:T:C | F376L | 0.917 |
| 1:12666639:T:A | F376L | 0.917 |
| 1:12666639:T:G | F376L | 0.917 |
| 1:12666028:T:C | F173L | 0.915 |
| 1:12666030:C:A | F173L | 0.915 |
| 1:12666030:C:G | F173L | 0.915 |
| 1:12666536:T:A | V342E | 0.915 |
| 1:12666029:T:C | F173S | 0.914 |
| 1:12666160:G:C | A217P | 0.910 |
| 1:12666562:G:C | D351H | 0.909 |
| 1:12666391:T:C | F294L | 0.906 |
| 1:12666393:T:A | F294L | 0.906 |
| 1:12666393:T:G | F294L | 0.906 |
| 1:12651294:G:C | G114R | 0.901 |
| 1:12651123:G:A | G57R | 0.897 |
| 1:12651123:G:C | G57R | 0.897 |
| 1:12666568:A:C | S353R | 0.894 |
| 1:12666570:C:A | S353R | 0.894 |
dbSNP variants (sampled 300 via entrez): RS1000070273 (1:12662374 T>C), RS1000108427 (1:12643497 C>T), RS1000129460 (1:12665348 G>A), RS1000194867 (1:12665585 A>G), RS1000310995 (1:12665803 C>T), RS1000393608 (1:12660087 G>C), RS1000434004 (1:12654300 T>C,G), RS1000448152 (1:12648853 G>A,T), RS1000594952 (1:12643845 C>T), RS1000677548 (1:12661105 G>A), RS1000736960 (1:12659817 T>C), RS1000777134 (1:12655423 G>A), RS1000830161 (1:12655796 C>G), RS1000895024 (1:12660181 C>A,T), RS1001050888 (1:12644953 T>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001762_123 | Obesity-related traits | 8.000000e-06 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
3 total (human), top 3 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Acetaminophen | decreases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Permethrin | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.